Do GLP-1 supplements work? What to know about ‘nature's Ozempic'
The products are being advertised as more affordable alternatives to blockbuster weight-loss drugs. Here’s what doctors think ...
US FDA approves Zevra's treatment for rare genetic disease
The U.S. Food and Drug Administration approved Zevra Therapeutics' drug for a rare and fatal genetic disorder, making it the ...
Don’t use this nasal spray, FDA says, it might be contaminated
The spray was distributed by Green Pharmaceuticals Inc., of Camarillo, Calif., and had been sold on the company’s website and ...
Nationwide Snack Recall Update As FDA Sets Highest Risk Level
The snacks now have a Class I risk level, meaning there is a "reasonable probability" they could cause "serious adverse ...
FDA Approves First Treatment for Niemann-Pick Disease, Type C
Today, the U.S. Food and Drug Administration approved Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC). Miplyffa, in combination with the enzyme ...
Drug Store News13m
FDA approves Roche’s Ocrevus Zunovo with Halozyme’s Enhanze drug delivery technology
Ocrevus Zunovo with Halozyme's Enhanze drug delivery technology is used for the treatment of relapsing multiple sclerosis and ...
Magazine: Enhancing therapy adherence with prodrugs
Solving adherence issues with prodrugs, examining whether PBMs are to blame for high drugs prices in the US, developing ...
ConsumerAffairs24m
Supplements recalled because they contain undeclared drugs
Herbals LLC has issued a nationwide recall of all lots of Vail-Bon Jie Yang Wan  supplement capsules due to the presence of ...
FDA Approves Zevra's Miplyffa for Niemann-Pick Disease Type C
Zevra Therapeutics has won Food and Drug Administration approval of Miplyffa for Niemann-Pick disease type C, making it the first drug cleared in the U.S. for the rare neurodegenerative disorder.
Canadian Manufacturing30m
Navident EVO receives FDA clearance for medical product
An Endodontic mode has been created within the Navident EVO system, reportedly improving the ability of the clinician to effectively detect, diagnose, and plan treatment prior to dynamic navigation.
Where Will Amgen Be in 5 Years?
Beyond MariTide, Amgen has a rich pipeline with more than 30 phase 3 programs. Some are for existing medicines seeking label expansions, such as Lumakras and Amjevita, a rheumatoid arthritis medicine.
Two Deaths Linked to Abortion Pills Despite Experts Saying They Are Safe
Amber Thurman died after waiting 20 hours for medical treatment following the use of abortion pills, marking the first ...